Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Aminocaproic-acid | hsa00030 | Pentose phosphate pathway | 5.07E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Aminocaproic-acid | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Aminocaproic-acid | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Aminocaproic-acid | hsa00500 | Starch and sucrose metabolism | 1.92E-05 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Aminocaproic-acid | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Aminocaproic-acid | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 1.34E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Aminocaproic-acid | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.29E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Aminocaproic-acid | hsa00730 | Thiamine metabolism | 1.44E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Aminocaproic-acid | hsa00790 | Folate biosynthesis | 4.05E-02 | 2 | Q92820, P42330 | GGH, AKR1C3 | More | | Aminocaproic-acid | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Aminocaproic-acid | hsa00970 | Aminoacyl-tRNA biosynthesis | 5.32E-03 | 3 | O95363, P54136, Q15046 | FARS2, RARS1, KARS | More | | Aminocaproic-acid | hsa00983 | Drug metabolism - other enzymes | 6.73E-05 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Aminocaproic-acid | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | | Aminocaproic-acid | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Aminocaproic-acid | hsa03013 | RNA transport | 4.09E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Aminocaproic-acid | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Aminocaproic-acid | hsa04024 | cAMP signaling pathway | 3.37E-02 | 3 | P63092, P26678, P61586 | GNAS, PLN, RHOA | More | | Aminocaproic-acid | hsa04060 | Cytokine-cytokine receptor interaction | 1.74E-04 | 17 | P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P19875, P18510, P01730, Q93038 | IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CXCL2, IL1RN, CD4, TNFRSF25 | More | | Aminocaproic-acid | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.72E-05 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Aminocaproic-acid | hsa04062 | Chemokine signaling pathway | 3.27E-04 | 10 | P25024, P25025, P09341, P19875, P07948, P42338, P19174, P63218, P50151, P43250 | CXCR1, CXCR2, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6 | More | | Aminocaproic-acid | hsa04064 | NF-kappa B signaling pathway | 3.15E-10 | 20 | P10415, Q13489, P25963, P51617, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P24522, O75293, P09341, P19875, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, GADD45A, GADD45B, CXCL1, CXCL2, LTB | More | | Aminocaproic-acid | hsa04071 | Sphingolipid signaling pathway | 2.67E-05 | 9 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2, Q02156 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2, PRKCE | More | | Aminocaproic-acid | hsa04072 | Phospholipase D signaling pathway | 5.37E-03 | 8 | P42338, P61586, P43657, P25024, P25025, P19174, O14986, P63092 | PIK3CB, RHOA, P2RY5, CXCR1, CXCR2, PLCG1, PIP5K1B, GNAS | More | | Aminocaproic-acid | hsa04080 | Neuroactive ligand-receptor interaction | 1.83E-04 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1 | More | | Aminocaproic-acid | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Aminocaproic-acid | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Aminocaproic-acid | hsa04145 | Phagosome | 1.53E-03 | 9 | Q15080, P14598, Q13509, Q13488, P05164, P78380, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Aminocaproic-acid | hsa04210 | Apoptosis | 1.09E-03 | 12 | Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, P18848, Q14643 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ATF4, ITPR1 | More | | Aminocaproic-acid | hsa04213 | Longevity regulating pathway - multiple species | 3.66E-03 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Aminocaproic-acid | hsa04270 | Vascular smooth muscle contraction | 4.59E-02 | 1 | Q02156 | PRKCE | More | | Aminocaproic-acid | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Aminocaproic-acid | hsa04340 | Hedgehog signaling pathway | 1.88E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Aminocaproic-acid | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Aminocaproic-acid | hsa04510 | Focal adhesion | 4.07E-02 | 3 | O14986, P61586, Q16363 | PIP5K1B, RHOA, LAMA4 | More | | Aminocaproic-acid | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | | Aminocaproic-acid | hsa04610 | Complement and coagulation cascades | 8.87E-08 | 2 | P00734, P0C0L4 | F2, C4A | More | | Aminocaproic-acid | hsa04612 | Antigen processing and presentation | 1.41E-07 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Aminocaproic-acid | hsa04613 | Neutrophil extracellular trap formation | 7.28E-05 | 13 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, P14598, Q15080, P20160, P08311, P49913, P21730, P21462 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | | Aminocaproic-acid | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Aminocaproic-acid | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Aminocaproic-acid | hsa04640 | Hematopoietic cell lineage | 1.39E-05 | 13 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Aminocaproic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 6.92E-11 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P49863 | GZMK | Granzyme K | P01375 | TNF | Tumor necrosis factor | -0.8 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.718 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P06239 | LCK | Tyrosine-protein kinase Lck | -0.709 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.764 | P24158 | PRTN3 | Myeloblastin | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.816 | P51124 | GZMM | Granzyme M | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.743 | P49863 | GZMK | Granzyme K | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.899 | P08311 | CTSG | Cathepsin G | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.92 | P20160 | AZU1 | Azurocidin | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.81 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.703 | P24158 | PRTN3 | Myeloblastin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.729 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P20160 | AZU1 | Azurocidin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P51124 | GZMM | Granzyme M | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.834 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P24158 | PRTN3 | Myeloblastin | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.732 | P49863 | GZMK | Granzyme K | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.809 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | P20160 | AZU1 | Azurocidin | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.744 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.803 | P24158 | PRTN3 | Myeloblastin | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.76 | P51124 | GZMM | Granzyme M | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.713 | P49863 | GZMK | Granzyme K | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.96 | P08311 | CTSG | Cathepsin G | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.875 | P20160 | AZU1 | Azurocidin | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.763 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P49863 | GZMK | Granzyme K | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.775 | P24158 | PRTN3 | Myeloblastin | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.77 | P49863 | GZMK | Granzyme K | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | P20160 | AZU1 | Azurocidin | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.765 | P24158 | PRTN3 | Myeloblastin | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.77 | P49863 | GZMK | Granzyme K | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P20160 | AZU1 | Azurocidin | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.765 |
| Aminocaproic-acid | hsa04657 | IL-17 signaling pathway | 4.00E-05 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Aminocaproic-acid | hsa04658 | Th1 and Th2 cell differentiation | 3.74E-16 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P20160 | AZU1 | Azurocidin | Q04759 | PRKCQ | Protein kinase C theta type | -0.912 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.703 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P20160 | AZU1 | Azurocidin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.787 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.734 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.901 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P06239 | LCK | Tyrosine-protein kinase Lck | -0.709 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P49863 | GZMK | Granzyme K | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.848 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P20160 | AZU1 | Azurocidin | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.724 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P20160 | AZU1 | Azurocidin | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.833 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.73 | P51124 | GZMM | Granzyme M | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.755 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P51124 | GZMM | Granzyme M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.887 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.731 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P20160 | AZU1 | Azurocidin | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.79 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 | P51124 | GZMM | Granzyme M | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.849 | P49863 | GZMK | Granzyme K | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.704 |
| Aminocaproic-acid | hsa04659 | Th17 cell differentiation | 1.73E-12 | 14 | Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P20160 | AZU1 | Azurocidin | Q04759 | PRKCQ | Protein kinase C theta type | -0.912 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.901 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P06239 | LCK | Tyrosine-protein kinase Lck | -0.709 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P51124 | GZMM | Granzyme M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.887 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.731 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P20160 | AZU1 | Azurocidin | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.79 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.909 | P51124 | GZMM | Granzyme M | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.886 | P49863 | GZMK | Granzyme K | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.722 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 | P20160 | AZU1 | Azurocidin | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.741 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.73 | P51124 | GZMM | Granzyme M | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.755 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P20160 | AZU1 | Azurocidin | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.833 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.734 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.703 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P20160 | AZU1 | Azurocidin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.787 |
| Aminocaproic-acid | hsa04660 | T cell receptor signaling pathway | 1.18E-09 | 18 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Aminocaproic-acid | hsa04662 | B cell receptor signaling pathway | 1.07E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Aminocaproic-acid | hsa04664 | Fc epsilon RI signaling pathway | 1.24E-03 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Aminocaproic-acid | hsa04666 | Fc gamma R-mediated phagocytosis | 4.59E-02 | 1 | Q02156 | PRKCE | More | | Aminocaproic-acid | hsa04668 | TNF signaling pathway | 1.94E-04 | 9 | P01375, O00463, Q13489, Q16539, P25963, P09341, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, CXCL1, BCL3, TRAF1, MMP9 | More | | Aminocaproic-acid | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Aminocaproic-acid | hsa04713 | Circadian entrainment | 4.94E-02 | 2 | P62873, P63092 | GNB1, GNAS | More | | Aminocaproic-acid | hsa04720 | Long-term potentiation | 2.62E-02 | 3 | P18848, P22694, Q14643 | ATF4, PRKACB, ITPR1 | More | | Aminocaproic-acid | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | | Aminocaproic-acid | hsa04724 | Glutamatergic synapse | 2.90E-03 | 6 | P43003, P63092, P62873, P63218, P50151, P15104 | SLC1A3, GNAS, GNB1, GNG5, GNG10, GLUL | More | | Aminocaproic-acid | hsa04725 | Cholinergic synapse | 3.86E-02 | 4 | P22694, Q14643, P18848, P10415 | PRKACB, ITPR1, ATF4, BCL2 | More | | Aminocaproic-acid | hsa04726 | Serotonergic synapse | 2.52E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | | Aminocaproic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.75E-05 | 9 | P14778, Q02156, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759 | IL1R1, PRKCE, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Aminocaproic-acid | hsa04912 | GnRH signaling pathway | 2.62E-02 | 3 | P18848, Q14643, P22694 | ATF4, ITPR1, PRKACB | More | | Aminocaproic-acid | hsa04913 | Ovarian steroidogenesis | 4.05E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Aminocaproic-acid | hsa04915 | Estrogen signaling pathway | 1.67E-03 | 5 | P14780, P22694, P18848, Q14643, P10415 | MMP9, PRKACB, ATF4, ITPR1, BCL2 | More | | Aminocaproic-acid | hsa04918 | Thyroid hormone synthesis | 7.24E-04 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | | Aminocaproic-acid | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Aminocaproic-acid | hsa04922 | Glucagon signaling pathway | 2.11E-02 | 4 | P22694, P06737, P18848, Q14643 | PRKACB, PYGL, ATF4, ITPR1 | More | | Aminocaproic-acid | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Aminocaproic-acid | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Aminocaproic-acid | hsa04925 | Aldosterone synthesis and secretion | 1.93E-02 | 4 | Q14643, P18848, Q02156, P22694 | ITPR1, ATF4, PRKCE, PRKACB | More | | Aminocaproic-acid | hsa04927 | Cortisol synthesis and secretion | 3.17E-05 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Aminocaproic-acid | hsa04928 | Parathyroid hormone synthesis, secretion and action | 9.12E-04 | 5 | Q14643, P22694, P23771, P18848, P10415 | ITPR1, PRKACB, GATA3, ATF4, BCL2 | More | | Aminocaproic-acid | hsa04930 | Type II diabetes mellitus | 9.93E-03 | 1 | Q02156 | PRKCE | More | | Aminocaproic-acid | hsa04931 | Insulin resistance | 2.64E-02 | 1 | Q02156 | PRKCE | More | | Aminocaproic-acid | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.31E-02 | 1 | Q02156 | PRKCE | More | | Aminocaproic-acid | hsa04934 | Cushing syndrome | 4.06E-02 | 5 | Q14643, P22694, P49841, Q9UJU2, O00170 | ITPR1, PRKACB, GSK3B, LEF1, AIP | More | | Aminocaproic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Aminocaproic-acid | hsa04970 | Salivary secretion | 4.49E-02 | 4 | P22694, Q14643, P17252, P49913 | PRKACB, ITPR1, PRKCA, CAMP | More | | Aminocaproic-acid | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | | Aminocaproic-acid | hsa04973 | Carbohydrate digestion and absorption | 1.66E-04 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Aminocaproic-acid | hsa04974 | Protein digestion and absorption | 9.93E-03 | 1 | Q7Z2H8 | SLC36A1 | More | | Aminocaproic-acid | hsa05032 | Morphine addiction | 2.47E-03 | 3 | P62873, P48169, P63092 | GNB1, GABRA4, GNAS | More | | Aminocaproic-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.00E-05 | 6 | P09341, P19875, P19174, P25024, P25025, P07948 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Aminocaproic-acid | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Aminocaproic-acid | hsa05132 | Salmonella infection | 2.98E-02 | 11 | P51617, P25963, P01375, Q9UJU2, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, Q13509 | IRAK1, NFKBIA, TNF, LEF1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, TUBB3 | More | | Aminocaproic-acid | hsa05133 | Pertussis | 2.95E-03 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Aminocaproic-acid | hsa05134 | Legionellosis | 4.00E-04 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Aminocaproic-acid | hsa05135 | Yersinia infection | 4.26E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | | Aminocaproic-acid | hsa05140 | Leishmaniasis | 1.18E-02 | 7 | P14598, P13765, O60603, P25963, P01375, P51617, Q15080 | NCF1, HLA-DOB, TLR2, NFKBIA, TNF, IRAK1, NCF4 | More | | Aminocaproic-acid | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Aminocaproic-acid | hsa05144 | Malaria | 9.48E-05 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Aminocaproic-acid | hsa05145 | Toxoplasmosis | 3.07E-02 | 7 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2 | More | | Aminocaproic-acid | hsa05146 | Amoebiasis | 1.43E-11 | 13 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Aminocaproic-acid | hsa05150 | Staphylococcus aureus infection | 4.36E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | | Aminocaproic-acid | hsa05152 | Tuberculosis | 3.11E-03 | 9 | Q13488, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | TCIRG1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Aminocaproic-acid | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Aminocaproic-acid | hsa05163 | Human cytomegalovirus infection | 2.73E-04 | 16 | P42338, P01375, P62873, P63218, P50151, P61586, P49841, P01106, P14778, Q13651, P25025, Q16539, P63092, O00463, P30101, P61769 | PIK3CB, TNF, GNB1, GNG5, GNG10, RHOA, GSK3B, MYC, IL1R1, IL10RA, CXCR2, MAPK14, GNAS, TRAF5, PDIA3, B2M | More | | Aminocaproic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.60E-03 | 8 | P42338, P63218, P50151, P09341, P19875, P19174, P07948, P01106 | PIK3CB, GNG5, GNG10, CXCL1, CXCL2, PLCG1, LYN, MYC | More | | Aminocaproic-acid | hsa05169 | Epstein-Barr virus infection | 1.82E-03 | 15 | P13765, P01106, Q13547, O00463, Q16539, P42338, P07948, P30101, Q13761, P24522, O75293, O60603, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, MAPK14, PIK3CB, LYN, PDIA3, RUNX3, GADD45A, GADD45B, TLR2, CD3E, CD3G, CD247 | More | | Aminocaproic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 1.21E-04 | 21 | P42338, P63218, P50151, P01375, P17252, O00463, P30101, Q14643, P01730, P51617, P25963, O60603, Q13315, O95067, P19174, P07766, P20963, P10415, Q13619, Q93034, Q9Y6Q5 | PIK3CB, GNG5, GNG10, TNF, PRKCA, TRAF5, PDIA3, ITPR1, CD4, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, CD3E, CD247, BCL2, CUL4A, CUL5, AP1M2 | More | | Aminocaproic-acid | hsa05202 | Transcriptional misregulation in cancer | 4.42E-08 | 17 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Aminocaproic-acid | hsa05214 | Glioma | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Aminocaproic-acid | hsa05217 | Basal cell carcinoma | 3.39E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Aminocaproic-acid | hsa05218 | Melanoma | 1.34E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Aminocaproic-acid | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Aminocaproic-acid | hsa05230 | Central carbon metabolism in cancer | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Aminocaproic-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.61E-07 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Aminocaproic-acid | hsa05310 | Asthma | 6.09E-07 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Aminocaproic-acid | hsa05321 | Inflammatory bowel disease | 1.48E-11 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Aminocaproic-acid | hsa05322 | Systemic lupus erythematosus | 4.90E-03 | 9 | P08246, P08311, P01375, P10747, P13765, Q6FI13, Q16778, P12814, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST2H2BE, ACTN1, SSB | More | | Aminocaproic-acid | hsa05323 | Rheumatoid arthritis | 2.72E-02 | 4 | P01375, P13765, P09341, O60603 | TNF, HLA-DOB, CXCL1, TLR2 | More | | Aminocaproic-acid | hsa05332 | Graft-versus-host disease | 5.65E-09 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Aminocaproic-acid | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |